Suffering from a dramatic tailspin in drug sales, AstraZeneca ($AZN) will be shrinking its profile at pharma industry events. The pharma giant has banned all "non-essential" travel overseas and reduced its events team in London from 6 to only two, according to Conference & Incentive Travel. An AstraZeneca spokesperson said that the company is planning far fewer events, so doesn't need the same size staff. The pharma company has been laying off thousands of workers as it tries to restructure its pipeline effort and start winning new drug approvals. Story